X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical Epidemiology

期刊標題檢索 CLIN EPIDEMIOL 最新評論: Has anything changed, it's been 40 days for me too (2024-05-23)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical Epidemiology]您好,您是該頁面的第 27230 位訪客。

期刊簡介
期刊名稱Clinical Epidemiology Clinical Epidemiology
LetPub Score
6.1
50 ratings
Rate

Reputation
7.1

Influence
5.0

Speed
7.1

期刊簡稱CLIN EPIDEMIOL
ISSN1179-1349
h-index49
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.301.6951.491
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Epidemiology
Q241 / 148

自引率 (2023-2024)5.90%自引率趨勢
掲載範囲
Clinical Epidemiology is an international, peer reviewed, open access journal. Clinical Epidemiology focuses on the application of epidemiological principles and questions relating to patients and clinical care in terms of prevention, diagnosis, prognosis, and treatment.

Clinical Epidemiology welcomes papers covering these topics in form of original research and systematic reviews.

Clinical Epidemiology has a special interest in international electronic medical patient records and other routine health care data, especially as applied to safety of medical interventions, clinical utility of diagnostic procedures, understanding short- and long-term clinical course of diseases, clinical epidemiological and biostatistical methods, and systematic reviews.

When considering submission of a paper utilizing publicly-available data, authors should ensure that such studies add significantly to the body of knowledge and that they use appropriate validated methods for identifying health outcomes.

The journal has launched special series describing existing data sources for clinical epidemiology, international health care systems and validation studies of algorithms based on databases and registries.
官方網站https://www.dovepress.com/clinical-epidemiology-journal
在線稿件提交https://www.dovepress.com/submit_step_1.php
開放訪問Yes
出版商Dove Medical Press Ltd.
主題領域Medicine
出版國/地區NEW ZEALAND
發行頻率
創刊年0
每年文章數96每年文章數趨勢
黃金OA百分比97.54%
OA Related Info
APC: Yes( USD3300; )
APC waiver:Check Notes
Other charges: No
Keywords: epidemiology、health care data、biostatistical methods
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTHSCIEQ192/403
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1179-1349%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 16 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Clinical Epidemiology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Microbial GenomicsH-index: 0

    CiteScore: 6.60
    Journal of Epidemiology and Global HealthH-index: 0

    CiteScore: 10.70
    Emerging Themes in EpidemiologyH-index: 0

    CiteScore: 4.40
    Iranian Journal of EpidemiologyH-index: 0

    CiteScore: 0.60
    Revista BionaturaH-index: 0

    CiteScore: 0.50
    Norsk EpidemiologiH-index: 0

    CiteScore: 1.10
    Infection Epidemiology and MicrobiologyH-index: 0

    CiteScore: 0.50
    Journal of Biostatistics and EpidemiologyH-index: 0

    CiteScore: 0.80
    Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiiaH-index: 0

    CiteScore: 0.90
    tHqyqt nZm slmtH-index: 0

    CiteScore: 0.30
    學科內最受檢索的期刊 頁面查看次數
    Microbial Genomics20622
    Journal of Epidemiology and Global Health9423
    Emerging Themes in Epidemiology1746
    Klinicheskaia mikrobiologiia i antimikrobnaia khimioterapiia1709
    Turkish Journal of Public Health1574
    Norsk Epidemiologi1551
    Revista Bionatura1480
    Journal of Biostatistics and Epidemiology1452
    Iranian Journal of Epidemiology1423
    Infection Epidemiology and Microbiology1375
  •  

    Clinical Epidemiology Clinical Epidemiology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [Clinical Epidemiology] 的評論撰寫評論
作者: 黑山静丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 22:36:04 評論於
Has anything changed, it's been 40 days for me too
(0) 讚! | 黑山静丝

作者: 极乐白玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-05 13:09:24 評論於
40 days, still 1A
(0) 讚! | 极乐白玉

作者: 邻家力言


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-20 22:37:24 評論於
It's been 40 days and we're still at 1A
(0) 讚! | 邻家力言

作者: 极乐白玉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 23:21:37 評論於
Hello, may I ask how long it took for you to receive approval? It has been 20 days for me and I am still at stage 1A
(0) 讚! | 极乐白玉

作者: 春竹来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-05 23:11:22 評論於
Hello, did you receive my article in the end? Thank you
(0) 讚! | 春竹来了

作者: Marian Max


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-02-23 08:09:03 評論於
 (0) 讚! | Marian Max  

作者: 南川阳嘉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-05 10:12:36 評論於
Have you ever encountered 1f magazine? Is it easy to win?
(0) 讚! | 南川阳嘉

作者: 珉林惜真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-04 19:40:28 評論於
How long have you been waiting, roughly?
(0) 讚! | 珉林惜真

作者: 珉林惜真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-04 15:17:15 評論於
Wow, you're so slow. It's been a month and you still haven't submitted for review. I've been in 1a status all this time
(0) 讚! | 珉林惜真

作者: 书生如馨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-03 21:15:18 評論於
Not yet, but the editing process has begun. It is currently undergoing compliance checks
(0) 讚! | 书生如馨

作者: 珉林惜真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-01 16:56:02 評論於
Is it under review now?
(0) 讚! | 珉林惜真

作者: 天山流逸


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-25 15:09:56 評論於
Too much talking
(0) 讚! | 天山流逸

作者: 书生如馨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-05 21:26:54 評論於
What's been going on with the magazines lately? Are the editors on a collective vacation? I submitted this magazine last year and it took 4 days to review, but this year, after 12 days, it's still an unevaluated submission
(0) 讚! | 书生如馨

作者: 慧娜mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-12 21:04:26 評論於
2D, make a wish and it might come true. Otherwise, it will be postponed
(0) 讚! | 慧娜mm

作者: 黑山翠花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-04 14:51:36 評論於
Has your article been accepted? My article is currently in the same state
(0) 讚! | 黑山翠花

作者: 慧娜mm


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-01 21:49:47 評論於
Has your article been accepted?
(0) 讚! | 慧娜mm

作者: 紫夏少爷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-06 17:16:45 評論於
How long has the 1a status been maintained?
(0) 讚! | 紫夏少爷

作者: 黑山翠花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-10 19:45:36 評論於
Okay, thank you
(0) 讚! | 黑山翠花

作者: 深渊倩语


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-10 15:49:30 評論於
It's probably been a little over a week, I can't remember the exact time
(0) 讚! | 深渊倩语

作者: 黑山翠花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-09 15:46:20 評論於
When did you make the investment? How long did the 1A status last? My 1A status lasted a long time
(0) 讚! | 黑山翠花

作者: 黑山翠花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-09 12:48:53 評論於
Excuse me, how long has your 1A status been going on?
(0) 讚! | 黑山翠花

作者: 深渊倩语


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-08 15:54:37 評論於
How long did Editor-in-chief's decision to maintain the status of 2G last? Thank you!
(0) 讚! | 深渊倩语

作者: 深渊倩语


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-08 14:14:26 評論於
How long did the state of 2g last that the editor made! Thank you!
(0) 讚! | 深渊倩语

作者: 深渊倩语


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-08 13:06:22 評論於
How long have you been in a state of 2g, the decision made by the editor! Thank you!
(0) 讚! | 深渊倩语

作者: 黑山翠花


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-04 12:17:16 評論於
How long has your 1a status lasted?
(0) 讚! | 黑山翠花

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [Clinical Epidemiology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*